Hermetica Superfood Encyclopedia
The Short Answer
Pleurotus sajor-caju contains lovastatin, beta-sitosterol, polysaccharides, phenolic compounds, and flavonoids that collectively exert hypocholesterolemic, antioxidant, immunomodulatory, and antitumor activities through HMG-CoA reductase inhibition, free radical scavenging, and innate immune activation. In preclinical models, the polysaccharide fraction PE1 administered intraperitoneally at doses of 3–100 mg/kg for 10 days inhibited sarcoma 180 tumor growth by up to 86%, while methanolic extracts demonstrated 88.0 ± 0.68% DPPH free radical scavenging activity at tested concentrations.
CategoryMushroom
GroupMushroom/Fungi
Evidence LevelPreliminary
Primary KeywordPleurotus sajor-caju benefits
Grey Oyster Mushroom — botanical close-up
Health Benefits
**Hypocholesterolemic Activity**
Pleurotus sajor-caju contains lovastatin, a naturally occurring HMG-CoA reductase inhibitor, along with beta-sitosterol and cholestanol, which competitively inhibit intestinal cholesterol absorption and reduce endogenous cholesterol biosynthesis in the liver.
**Antioxidant Protection**: Methanolic extracts rich in total phenols (52
2 ± 1.64 mg/g as tannic acid equivalent) and flavonoids (4.7 ± 0.05 mg/g as quercetin equivalent) achieve up to 88.0 ± 0.68% DPPH free radical scavenging, while ascorbic acid content (8.3 ± 0.73 mg/g) contributes additional electron-donation capacity.
**Antitumor and Immunomodulatory Effects**
Polysaccharide fractions PM1, PM2, and PE1 derived from mycelia stimulate innate immune responses, enhance superoxide dismutase (SOD) and glutathione peroxidase (GPx) activity, and reduced lipid peroxidation markers (TBARS, LOOH) in experimental tumor models.
**Antibacterial Activity**
Bioactive volatiles and sterols identified by GC-MS, including beta-sitosterol and hexadecanoic acid, disrupt bacterial membrane integrity against both Gram-positive and Gram-negative organisms, supporting traditional use as an antimicrobial food.
**Nutritional Density and Metabolic Support**: Providing 29
3 ± 1.03 g protein, 12.3 ± 0.26 g crude fiber, and only 0.9 ± 0.06 g fat per 100 g dry weight, the mushroom offers a high-protein, low-fat dietary profile supporting metabolic health, glycemic regulation, and satiety.
**Mineral Repletion**: Exceptionally high calcium (505
0 ± 4.64 mg/100 g dry weight), iron (109.5 ± 3.02 mg/100 g), and magnesium (108.7 ± 2.12 mg/100 g) concentrations make Pleurotus sajor-caju a potential dietary source for addressing mineral deficiencies in populations reliant on plant-based diets.
**Antidiabetic Potential**
Polysaccharides and beta-glucans within the fruiting body are proposed to modulate postprandial glucose absorption through viscous fiber effects and potential alpha-glucosidase inhibition, consistent with traditional antidiabetic applications documented in South Asian ethnomycology.
Origin & History
Natural habitat
Pleurotus sajor-caju is a tropical and subtropical edible basidiomycete mushroom native to South and Southeast Asia, including India, Sri Lanka, Thailand, and the Philippines, where it grows saprophytically on dead or decaying hardwood logs, agricultural residues such as straw, and lignocellulosic substrates. It thrives in warm, humid climates with temperatures between 25–30°C and high relative humidity, making it well-suited for cultivation in tropical regions. Commercially cultivated on substrates including paddy straw, sawdust, cotton waste, and soybean hull, its protein content varies with substrate composition, ranging from approximately 25.6 to 44.3 g per 100 g dry weight.
“Pleurotus sajor-caju has been consumed as an edible mushroom across South and Southeast Asia for centuries, particularly in India, Thailand, the Philippines, and Sri Lanka, where it is cultivated on agricultural waste substrates and valued both as a protein-rich food and as a traditional remedy. In Ayurvedic and folk medicinal traditions of the Indian subcontinent, oyster mushrooms of the Pleurotus genus have been employed for their purported antimicrobial, cholesterol-lowering, antidiabetic, and immune-enhancing properties, with preparations typically involving decoction, drying, or fresh consumption in curries and soups. Ethnomycological records document its role in supporting rural nutrition in developing regions where animal protein is scarce, reflecting its high protein content and favorable amino acid profile relative to most plant foods. The species gained scientific attention in the latter decades of the twentieth century when researchers began characterizing its polysaccharide and sterol content in the context of cancer immunotherapy and cardiovascular disease prevention research.”Traditional Medicine
Scientific Research
The evidence base for Pleurotus sajor-caju consists entirely of in vitro assays and animal model studies; no peer-reviewed human clinical trials have been published to date, representing a significant limitation in translating preclinical findings to clinical recommendations. In vitro antioxidant studies have quantified DPPH scavenging (effective concentration range 0.5–3 mg/ml), FRAP reduction (2–20 mg/ml), ferrous ion chelation, and hydrogen peroxide scavenging (3–18 mg/ml) in polysaccharide and methanolic extract fractions. The most rigorous preclinical study employed an intraperitoneal dosing protocol in sarcoma 180-bearing mice, wherein polysaccharide PE1 at doses of 3, 10, 30, and 100 mg/kg administered for 10 consecutive days produced dose-dependent tumor inhibition peaking at 86%, though specific sample sizes, p-values, and confidence intervals were not fully disclosed in available literature. Nutritional and phytochemical characterization studies using GC-MS, Folin-Ciocalteu, and atomic absorption spectroscopy provide well-replicated compositional data (protein 29.3 ± 1.03 g/100 g, phenols 52.2 ± 1.64 mg/g), but the absence of randomized controlled human trials means all health claims remain at the preclinical hypothesis-generating stage.
Preparation & Dosage
Traditional preparation
**Whole Dried Mushroom (Culinary)**
50–150 g fresh weight
Consumed as food in traditional diets at gram-scale quantities; no therapeutic dose established; typical culinary servings range from .
**Crude Methanolic Extract (Research Grade)**
5–20 mg/ml for antioxidant assays; no human dose equivalent established
Used in vitro at 0..
**Polysaccharide Fraction (Animal Studies)**
3–100 mg/kg body weight in murine models for 10 days; oral bioequivalence in humans is undetermined
PE1, PM1, and PM2 administered intraperitoneally at .
**Fermented Mycelial Preparation**
3 g/ml mycelial inoculum have been studied for exopolysaccharide (EPS) production; no standardized human supplemental form exists
Solid-state and liquid fermentation preparations using 0..
**Standardization**
No commercial standardization percentages for lovastatin, beta-glucan, or phenolic content in Pleurotus sajor-caju supplements have been established by regulatory agencies.
**Timing Notes**
As a food-based ingredient, consumption with meals may improve mineral bioavailability and moderate postprandial glycemic response; optimal timing for any pharmacological effect is not clinically defined.
Nutritional Profile
Per 100 g dry weight: protein 29.3 ± 1.03 g, total carbohydrates 62.9 ± 2.56 g, crude fiber 12.3 ± 0.26 g, crude fat 0.9 ± 0.06 g, energy 297.5 ± 9.31 kcal. Mineral content includes calcium 505.0 ± 4.64 mg, iron 109.5 ± 3.02 mg, magnesium 108.7 ± 2.12 mg, with lower concentrations of sodium, potassium, zinc, phosphorus, and trace elements nickel, manganese, and copper. Phytochemical profile includes total phenols 52.2 ± 1.64 mg/g (as tannic acid equivalent), flavonoids 4.7 ± 0.05 mg/g (as quercetin equivalent), ascorbic acid 8.3 ± 0.73 mg/g, beta-sitosterol, cholestanol, ergosterol (provitamin D2), lovastatin, and immunoactive polysaccharides including beta-glucans. Volatile aroma compounds identified by GC-MS include 1-octen-3-ol (5,000 µg/g in hot extract), hexadecanoic acid (6,118.52 µg/g), and octadecenoic acid (13,132.5 µg/g); lead content is low at 2.6 ± 2.01 mg/100 g. Bioavailability of iron and calcium from fungal sources may be modulated by co-occurring oxalate, phytate, and fiber fractions, though specific absorption studies for this species are lacking.
How It Works
Mechanism of Action
Lovastatin present in Pleurotus sajor-caju acts as a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, the rate-limiting enzyme in the mevalonate pathway of hepatic cholesterol synthesis, thereby reducing circulating LDL-cholesterol levels. Phenolic compounds and flavonoids donate hydrogen atoms to neutralize reactive oxygen species (ROS) including superoxide, hydroxyl radicals, and peroxy radicals, upregulating endogenous antioxidant enzymes SOD and GPx while suppressing lipid peroxidation end-products such as TBARS and lipid hydroperoxides (LOOH). Immunoactive polysaccharides (notably PE1, PM1, PM2) are believed to bind pattern-recognition receptors on macrophages and natural killer cells, activating the innate immune cascade and stimulating cytotoxic responses against neoplastic cells, as evidenced by tumor inhibition rates of up to 86% in murine sarcoma 180 models. Beta-sitosterol and cholestanol further reduce cholesterol absorption at the intestinal brush border by competing with dietary cholesterol for micellar incorporation and inhibiting Niemann-Pick C1-Like 1 (NPC1L1) transporter-mediated uptake.
Clinical Evidence
No human clinical trials investigating Pleurotus sajor-caju as a supplement or functional food ingredient have been identified in the peer-reviewed literature, and all outcome data originate from animal experiments or cell-based assays. The most quantified in vivo outcome is antitumor activity, with polysaccharide fraction PE1 achieving up to 86% inhibition of sarcoma 180 murine tumor growth over a 10-day intraperitoneal dosing regimen at 3–100 mg/kg; however, route of administration, tumor implantation model limitations, and absence of human pharmacokinetic data substantially restrict clinical extrapolation. Hypocholesterolemic effects attributed to lovastatin and phytosterol content are mechanistically plausible and supported by analogy with pharmaceutical statins and plant sterol research, but direct clinical measurement of LDL reduction following Pleurotus sajor-caju consumption has not been reported. Confidence in clinical efficacy is low given the complete absence of human trial data; well-designed pilot studies and phase I safety trials are required before therapeutic dosing guidance can be established.
Safety & Interactions
Pleurotus sajor-caju has a long history of safe dietary consumption across Asian populations with no documented serious adverse events attributable specifically to this species; low measured heavy metal content (lead 2.6 ± 2.01 mg/100 g dry weight) is consistent with general food safety standards for edible fungi. No formal drug interaction studies have been conducted; however, the presence of naturally occurring lovastatin raises a theoretical pharmacodynamic interaction risk with pharmaceutical HMG-CoA reductase inhibitors (statins), potentially additive myopathy or hepatotoxicity risk, and with CYP3A4 substrates given lovastatin's metabolism through this pathway. No contraindications have been established in the clinical literature; however, individuals with mushroom allergies, autoimmune conditions receiving immunosuppressive therapy (given polysaccharide immunostimulatory effects), or those on anticoagulant therapy should exercise caution given plausible but unstudied interactions. Data on safety during pregnancy and lactation are absent; conservative guidance would recommend limiting intake to culinary amounts until clinical safety data are available.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Pleurotus sajor-cajuGrey Oyster MushroomIndian Oyster MushroomSajor-caju Oyster MushroomPSC
Frequently Asked Questions
Does Pleurotus sajor-caju lower cholesterol?
Pleurotus sajor-caju contains naturally occurring lovastatin, an HMG-CoA reductase inhibitor that reduces hepatic cholesterol synthesis, as well as beta-sitosterol and cholestanol which compete with dietary cholesterol for intestinal absorption via the NPC1L1 transporter. While these mechanisms are well-established for pharmaceutical statins and isolated phytosterols, no human clinical trials have directly measured LDL cholesterol reduction following consumption of Pleurotus sajor-caju, so the magnitude of the hypocholesterolemic effect in humans remains unquantified.
What are the main bioactive compounds in Pleurotus sajor-caju?
The principal bioactive compounds include lovastatin (HMG-CoA reductase inhibitor), beta-glucan polysaccharides (fractions PE1, PM1, PM2 with immunomodulatory and antitumor activity), phenolic compounds (52.2 ± 1.64 mg/g as tannic acid equivalent), flavonoids (4.7 ± 0.05 mg/g as quercetin equivalent), ascorbic acid (8.3 ± 0.73 mg/g), ergosterol (provitamin D2), and phytosterols including beta-sitosterol and cholestanol. Volatile aroma compounds such as 1-octen-3-ol and hexadecanoic acid also contribute to its antibacterial properties as identified by GC-MS analysis.
Is Pleurotus sajor-caju the same as pink oyster mushroom?
Pleurotus sajor-caju is commonly referred to as the grey oyster mushroom or Indian oyster mushroom and is distinct from Pleurotus djamor, which is more widely known as the pink oyster mushroom, though some sources use the terms interchangeably due to regional naming variations. Taxonomically, P. sajor-caju is characterized by greyish-brown to tan fruiting bodies cultivated predominantly in South and Southeast Asia, and its biochemical profile—including lovastatin content and polysaccharide composition—may differ from other Pleurotus species with which it is sometimes confused.
What does the research say about Pleurotus sajor-caju and cancer?
Preclinical research demonstrated that the polysaccharide fraction PE1, administered intraperitoneally at doses of 3–100 mg/kg for 10 days in sarcoma 180-bearing mice, inhibited tumor growth by up to 86%, while lower-molecular-weight fractions PM1 and PM2 showed comparatively reduced inhibition. The antitumor mechanism is attributed to immunomodulation—specifically activation of SOD and GPx enzymes, reduction in lipid peroxidation markers, and stimulation of innate immune effector cells—but no human oncology trials exist, and the intraperitoneal route of administration in rodents does not directly translate to oral supplementation outcomes in humans.
What is a safe dose of Pleurotus sajor-caju supplement?
No standardized supplemental dose has been established for Pleurotus sajor-caju in human clinical trials; all therapeutic dosing data come from animal models using intraperitoneal polysaccharide injections at 3–100 mg/kg, which cannot be directly extrapolated to oral doses in humans. As a food, culinary consumption of 50–150 g fresh mushroom (approximately 5–15 g dry weight equivalent) is typical in Asian dietary traditions and is considered safe based on its long history of food use and low measured heavy metal content, but anyone taking statin medications should consult a healthcare provider before using concentrated extracts due to potential additive pharmacodynamic effects from the mushroom's natural lovastatin content.
Does Pleurotus sajor-caju interact with statin medications like atorvastatin or simvastatin?
Pleurotus sajor-caju contains naturally occurring lovastatin, which is a statin compound that works similarly to prescription statin medications by inhibiting HMG-CoA reductase. Taking this mushroom supplement alongside prescription statins could potentially amplify cholesterol-lowering effects and increase the risk of statin-related side effects such as muscle pain or liver enzyme elevation. It is strongly recommended to consult with a healthcare provider before combining Pleurotus sajor-caju supplements with statin medications to avoid additive effects.
Which form of Pleurotus sajor-caju supplement—dried mushroom, extract, or powder—has the highest bioavailability?
Standardized extracts, particularly methanolic or hot water extracts, typically deliver higher concentrations of bioactive compounds like phenolic compounds and lovastatin compared to whole dried mushroom powder. Hot water extraction is especially effective for breaking down the mushroom's chitin cell walls and releasing beta-glucans and other immune-supporting polysaccharides that would otherwise pass through the digestive system unabsorbed. For maximum bioavailability and therapeutic effect, standardized extracts with defined levels of active constituents are generally superior to raw dried powder.
Is Pleurotus sajor-caju safe for people with mushroom allergies or mold sensitivities?
Individuals with documented mushroom allergies or mold sensitivities should avoid Pleurotus sajor-caju supplements, as cross-reactivity is possible and the mushroom itself contains proteins that may trigger allergic responses in susceptible individuals. People with histamine intolerance should also exercise caution, as mushrooms are known to accumulate histamine during storage and processing. A patch test or consultation with an allergist is advisable before introducing this supplement if you have a history of fungal or mold-related allergic reactions.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w pleurotus-sajor-caju-grey-oyster-mushroom curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
